Source: Eur Respir J 2003; 22: 374-382
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Kips J.C., Anderson G.P., Fredberg J.J., Herz U., Inman M.D., Jordana M., Kemeny D.M., Lotvall J., Pauwels R.A., Plopper C.G., Schmidt D., Sterk P.J., Van Oosterhout A.J.M., Vargaftig B.B., Chung K.F.. Murine models of asthma. Eur Respir J 2003; 22: 374-382

Member's Comments

No comment yet.

Related content which might interest you: Murine models of asthma Source: Guideline 2003 Year: 2003 IL-13-dependent C3a-release in a murine model of allergic asthma Source: Annual Congress 2005 - Airway epithelial cells in asthma and COPD Year: 2005 ST2 gene knockout attenuates allergic airways disease Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs Year: 2006 Models of asthma employing ovalbumin in rats and mice: similarities and differences compared with patient asthma Source: Annual Congress 2005 - PG11 - Experimental models for COPD and asthma Year: 2005 Role of CD163 in human fatal asthma and murine asthma model. Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018 Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Analysis of mucus production in mouse models of allergic asthma Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010 Pharmacological characterization of the protective effect of benralizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 The effect of lipopolysaccharide-contaminated ovalbumin on airway inflammation and remodeling in a chronic murine asthma model Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 Treatment with gp120 reduces AHR and airway inflammation in a humanized mouse model of asthma bronchiale Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Deficiency of MMP-19 promotes allergen-induced eosinophil burden and airway responsiveness in mice Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma Year: 2007 Development of a mouse model of airway inflammation and remodeling in experimental asthma Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 Opioid-neurotensin hybrid influences pulmonary inflammatory process in murine model of non-atopic asthma. Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017 Obesity enhances allergen-induced airway inflammation in a murine model of asthma Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Plasma cells in the airways express neurotrophins and neurotrophin-receptors in a mouse model of chronic allergic asthma Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma Year: 2007 Respiratory viral infections as promoters of allergic sensitization and asthma in animal models Source: Eur Respir J 2002; 19: 341-349 Year: 2002 Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models Source: Eur Respir J 2008; 32: 487-502 Year: 2008 Role of mouse mast cell protease 4 in a murine model of allergic asthma Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma Year: 2007 Pharmacological characterization of the protective effect of mepolizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 PDE-4-inhibitor rolipram supports treg-mediated suppression in a murine model of allergic airway disease Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008